Replies to post #8328 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

I’m not sure I agree that GTC’s focus on CABG has increased. At various times, GTC has mentioned ATryn as a treatment for such acquired AT deficiencies as burns, CABG, trauma, bone marrow transplant, ALL, and several others including, of course, DIC.